← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Eikonizo Therapeutics, Inc.
Cambridge, MA
$1,309,438
Total funding
3
Grants
Funding over time
peak $809.7K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,309,438 · 3
By mechanism
R43$1,309,438 · 3
Investigators at Eikonizo Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Mechanistic Validation of Selective Brain-Penetrant HDAC6 Inhibitors as a Disease- Modifying Treatment for Tauopathies including Alzheimer's Disease$509,672
R43 · FY2020 · AG
Next-Generation CNS-Penetrant HDAC6 Inhibitors: Proof-of-Principle in Parkinson's Disease$499,766
R43 · FY2025 · NS
Targeting HDAC6 to Modulate Titin Stiffness for Dilated Cardiomyopathy Therapy$300,000
R43 · FY2020 · HL